MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CMPX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Compass Therapeutics (CMPX) Ownership - Who owns Compass Therapeutics?

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8099
Employees
39
Web
https://www.compasstherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
365.58M
P/E Ratio
N/A
Total Cash
194.69M
Projected Growth
N/A
Total Debt
9.79M
Revenue
N/A
Risk (Beta)
1.19
Dividend Yield
N/A
Total Cash/Share
1.08
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CMPX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CMPX
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8099
Employees
39
Web
https://www.compasstherapeutics.com